Johnson & Johnson buy umbi9414
Start price
30.06.11
/
50%
€45.88
Target price
30.12.11
€60.00
Performance (%)
12.28%
End price
30.12.11
€50.69
Summary
This prediction ended on 30.12.11 with a price of €50.69. The prediction had a final performance of 12.28%. umbi9414 has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | 1.671% | 1.671% | -5.889% | 1.285% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by umbi9414 for this prediction
In the thread Johnson & Johnson diskutieren
Moderates kaufen für Langfristanleger
Kaufen bis* 53,16155 Innerer Wert:* 66,45194 Verkaufen ab* 79,74233
* in Dollar...
Durchschnittswerte auf die Jahre 10 Jahre 5 Jahre 3 Jahre 1 Jahr Eigenkapitalrendite* 14,82% 13,98% 13,72% 12,96% Eigenkapitalwachstum #DIV/0! 11,94 8,36 8,69 Wachstum EPS #DIV/0! 7,89 10,27 8,64 Wachstum Umsatz #DIV/0! 4,21 0,31 -0,50
(Laufzeit überschritten)